Literature DB >> 21036766

Prognostic value of IL-6 in localized prostatic cancer.

Juan Alcover1, Xavier Filella, Pilar Luqué, Rafael Molina, Laura Izquierdo, Josep Maria Augé, Antonio Alcaraz.   

Abstract

AIM: The usefulness of interleukin 6 (IL-6) and its soluble receptor IL-6sR in the prediction of the biochemical recurrence was evaluated in patients with prostate cancer treated with radical prostatectomy. PATIENTS AND METHODS: IL-6 and sIL-6R serum levels were measured in 96 patients with prostate cancer.
RESULTS: Using the log-rank test, it was evident that patients with preoperative serum levels of IL-6 higher than 1.2 pg/ml had a significantly increased probability of biochemical recurrence (p=0.031). We also observed that the Gleason score was associated with the risk of progression (p=0.033), but no relation was observed with TNM classification, PSA, % free PSA or sIL-6R. In a multivariate analysis, only IL-6 serum levels remained as a predictor of biochemical recurrence (p=0.040).
CONCLUSION: The results presented here demonstrated the usefulness of IL-6 in predicting the biochemical progression of prostate cancer, pointing towards an association between inflammation and the aggressiveness of the tumor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036766

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer.

Authors:  Sabina Davidsson; Michelangelo Fiorentino; Ove Andrén; Fang Fang; Lorelei A Mucci; Eberhard Varenhorst; Katja Fall; Jennifer R Rider
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-27       Impact factor: 4.254

2.  JunD-mediated repression of GADD45α and γ regulates escape from cell death in prostate cancer.

Authors:  Luiz Fernando Zerbini; Jaíra Ferreira de Vasconcellos; Akos Czibere; Yihong Wang; Juliano D Paccez; Xuesong Gu; Jin-Rong Zhou; Towia A Libermann
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

Review 3.  Stimuli-induced organ-specific injury enhancement of organotropic metastasis in a spatiotemporal regulation.

Authors:  Dongwei Gao; Sha Li
Journal:  Pathol Oncol Res       Date:  2013-12-20       Impact factor: 3.201

4.  The PCa Tumor Microenvironment.

Authors:  Joseph L Sottnik; Jian Zhang; Jill A Macoska; Evan T Keller
Journal:  Cancer Microenviron       Date:  2011-07-05

5.  IL-6/IL-6R as a potential key signaling pathway in prostate cancer development.

Authors:  Andreia Azevedo; Virginia Cunha; Ana Luisa Teixeira; Rui Medeiros
Journal:  World J Clin Oncol       Date:  2011-12-10

6.  AT-rich interaction domain 5A regulates the transcription of interleukin-6 gene in prostate cancer cells.

Authors:  Wataru Ikeuchi; Yuriko Wakita; Guoxiang Zhang; Chun Li; Keiichi Itakura; Takahiro Yamakawa
Journal:  Prostate       Date:  2021-10-11       Impact factor: 4.104

7.  Prognostic value of interleukin-6 and interleukin-8 in laryngeal squamous cell cancer.

Authors:  Wenwei Hao; Yongping Zhu; Huifang Zhou
Journal:  Med Oncol       Date:  2012-12-27       Impact factor: 3.064

Review 8.  Immune mediators in the tumor microenvironment of prostate cancer.

Authors:  Jinlu Dai; Yi Lu; Hernan Roca; Jill M Keller; Jian Zhang; Laurie K McCauley; Evan T Keller
Journal:  Chin J Cancer       Date:  2017-03-14

Review 9.  The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.

Authors:  Paola De Cicco; Giuseppe Ercolano; Angela Ianaro
Journal:  Front Immunol       Date:  2020-07-30       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.